| Drugs by Condition |  |
Macular Degeneration Medications
Definition of Macular Degeneration: Macular degeneration is a disorder that affects the macula (the central part of the retina of the eye) causing decreased visual acuity and possible loss of central vision.
Drugs associated with Macular Degeneration
The following drugs and medications are in some way related to, or used in the treatment of Macular Degeneration.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
|---|---|---|
Avastin (Pro, More...)  generic name: bevacizumab class: antineoplastic monoclonal antibodies | 0 Review(s) | Not rated - Be the first |
| Lucentis (Pro, More...)generic name: ranibizumab class: anti-angiogenic ophthalmic agents | 0 Review(s) | Not rated - Be the first |
| Macugen (More...)generic name: pegaptanib class: anti-angiogenic ophthalmic agents | 0 Review(s) | Not rated - Be the first |
| Visudyne (Pro, More...)generic name: verteporfin class: miscellaneous uncategorized agents | 0 Review(s) | Not rated - Be the first |
Macular Degeneration Medications in the Pipeline
Retaane (anecortave acetate)
- September 25, 2007
Alcon Receives FDA Decision on Retaane Suspension for Wet AMD - May 24, 2005
Alcon Receives Approvable Letter from FDA for Retaane Suspension - December 16, 2004
Alcon Submits Retaane - Drug Applications to U.S. and European Regulatory Authorities - June 30, 2004
Alcon Updates Filing Status of Retaane New Drug Application
SnET2-PDT (Tin ethyl etiopurpurin (SnET2) photodynamic therapy (PDT))
Learn more about Macular Degeneration
Medical encyclopedia results for:
